Researchers at the Helmholtz Institute for Diabetes and Metabolic Diseases Research, affiliated with the University of Tübingen and Munich, report that weight loss can slow or halt the progression from prediabetes to type 2 diabetes for a subset of individuals. The findings were published in the journal Diabetologia.
The study enrolled 480 adults diagnosed with prediabetes, a condition defined by higher than normal blood glucose levels that have not yet reached diabetic thresholds. Prediabetes is widely recognized as a major risk factor for developing type 2 diabetes, especially with ongoing lifestyle factors such as diet and physical activity patterns.
Participants were guided to follow a dietary program designed to produce at least a 7 percent reduction in body weight by the end of the study period. Throughout the intervention, 114 volunteers achieved remission of their prediabetes. In practical terms, this meant improvements in fasting blood sugar, glycated hemoglobin HbA1c, and glucose tolerance tests returning to normal ranges.
However, the remaining 366 participants did not show meaningful metabolic improvements despite attaining a similar degree of weight loss.
On the whole, those who lost weight and reached prediabetic remission were less likely to advance to overt diabetes. The researchers observed a 76 percent relative reduction in the risk of developing diabetes among those whose blood sugar normalized, compared with individuals who did not achieve remission. In absolute terms, this risk reduction was greater than ten percentage points.
The authors noted that they could not pinpoint a single reason why some participants did not experience metabolic benefits from weight loss. They indicated that achieving remission may depend on achieving weight loss at a level that is highly personalized, potentially influenced by genetic, metabolic, and lifestyle factors.
Additional context from experts highlights that while weight loss is a powerful modifiable factor, individual responses vary. Ongoing research continues to explore how baseline metabolic health, duration of prediabetes, and concurrent cardiovascular risk factors interact with weight loss to influence remission rates. Clinicians emphasize that even partial improvements in weight and glucose regulation can contribute to better long-term outcomes, reinforcing the value of personalized strategies.
In practical terms for patients and clinicians, the study underscores the potential of sustained, clinically supervised weight reduction as a nonpharmacologic pathway to reduce diabetes risk. The results suggest that targeted weight management plans, combined with monitoring of fasting glucose and HbA1c levels, may help identify individuals most likely to benefit from aggressive lifestyle interventions.
As with many studies in metabolic health, the findings invite further investigation into how to tailor interventions to individual needs. The question of why some individuals experience remission while others do not remains an active area of inquiry, with implications for precision medicine in diabetes prevention. The data nevertheless reinforce a hopeful message: intentional weight loss, when achieved and maintained, can meaningfully reduce the likelihood of progressing to diabetes for many people.
In closing, the researchers conferred that proactive weight management stands as a cornerstone in the prevention toolkit for prediabetes, supporting the case for early lifestyle changes to mitigate future diabetes risk. This aligns with broader public health guidance that emphasizes healthy eating, regular activity, and regular screening to preserve metabolic health over time.
Russians before saidWhether to take statins if your sugar levels are high.